Glucose concentrations within target, appropriate gestational weight gain, adequate lifestyle,
and, if necessary, antihypertensive treatment and low-dose aspirin reduces the risk of pre …

Hyperglycemia is the commonest medical condition affecting pregnancy and its incidence is
increasing globally in parallel with the twin epidemics of diabetes and obesity. Both pre …

In women with type 1 diabetes, the risk of adverse pregnancy outcomes, including
congenital anomalies, preeclampsia, preterm delivery, foetal overgrowth and perinatal death …

Background Faster-acting insulin aspart (faster aspart) is considered safe for use during
pregnancy and breastfeeding but has not been evaluated in this population. We aimed to …

Introduction Information regarding the postpartum period in women with type 1 diabetes
(T1D) is scarce. We aim to evaluate the relation of impaired hypoglycaemia awareness (IAH) …

Introduction Faster-acting insulin aspart (Fiasp) is approved for use in pregnancy and
lactation, but no clinical study has evaluated its effects during this life stage in women with …

The relevance of type 1 diabetes during pregnancy stems from its impact on the health of
mother and offspring and its increasing prevalence. Glycemic control during pregnancy is …

Objective. To investigate the clinical effect of continuous subcutaneous injection of insulin
analogues in pregnant women with diabetes mellitus complicated with ketoacidosis …

Background & aim: Research has demonstrated the negative effects of type-1 diabetes
mellitus (T1DM) on the female sexual health and reproductive function. The present study …

This study identified the breastfeeding information and support needs of women with pre-
pregnancy diabetes and as a result, developed an informed educational resource. The study …